Search for: "Price v. Price et al" Results 881 - 900 of 1,523
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2010, 12:15 pm by Lawrence B. Ebert
” Herbert Hovenkamp et al., IP & Antitrust § 35.2b (2010). [read post]
17 Aug 2011, 2:00 am by Kara OBrien
The Plaintiffs’ motion is denied with respect to their other price and process claims. [read post]
19 Jun 2009, 8:21 am
Francica Escoto, et al., No. 06-0890 (Green, J.) [read post]
12 Mar 2010, 5:09 am
(Docket Report) (271 Patent Blog) District Court E D Texas: Defendant may not present jury argument concerning KSR’s change to obviousness standard: Datatreasurycorp v Wells Fargo & Co et al (Docket Report) District Court E Texas: Entire operating system cannot serve as royalty base where only the workspace switching feature is accused of infringement: IP Innovation, LLC. et al v. [read post]
12 Mar 2010, 5:09 am
(Docket Report) (271 Patent Blog) District Court E D Texas: Defendant may not present jury argument concerning KSR’s change to obviousness standard: Datatreasurycorp v Wells Fargo & Co et al (Docket Report) District Court E Texas: Entire operating system cannot serve as royalty base where only the workspace switching feature is accused of infringement: IP Innovation, LLC. et al v. [read post]
6 Oct 2014, 4:00 am by Administrator
Double AspectFor Sale, at the Right Price This morning, the Supreme Court of Canada has released its judgment in Trial Lawyers Association of British Columbia v. [read post]
16 Jun 2019, 3:00 am by Doug Cornelius
Stan Shiff, et al., Order Denying Petition for Writ of Habeus Corpus, 18cv0863 GPC Filed June 5, 2019Court Rules Lot Sales Were Sales Of Securities by Keith Paul Bishop [read post]
10 Sep 2011, 12:32 am by Marie Louise
(Spicy IP) (Spicy IP) US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al / ????????????????????????? [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
28 Oct 2010, 3:03 pm by Stephen Albainy-Jenei
   Association for Molecular Pathology, et al. v. [read post]
8 Aug 2023, 9:05 pm by renholding
 These activities are conducted on a large scale, with estimates of the total amount of corporate tax avoidance ranging from $212 billion (Tørsløv et al., 2022) to $600 billion (Crivelli et al., 2015). [read post]